Sarasin & Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$185M Buy
237,793
+9,735
+4% +$7.59M 1.85% 23
2025
Q1
$188M Sell
228,058
-27,437
-11% -$22.7M 2.04% 22
2024
Q4
$197M Buy
255,495
+15,260
+6% +$11.8M 2.18% 18
2024
Q3
$213M Sell
240,235
-74,186
-24% -$65.7M 2.01% 24
2024
Q2
$285M Buy
314,421
+38,597
+14% +$34.9M 2.52% 18
2024
Q1
$215M Buy
275,824
+28,335
+11% +$22M 2.11% 21
2023
Q4
$144M Buy
247,489
+237,478
+2,372% +$138M 1.59% 27
2023
Q3
$5.38M Buy
+10,011
New +$5.38M 0.07% 61
2023
Q2
Sell
-157,150
Closed -$43.2M 89
2023
Q1
$43.2M Buy
157,150
+127,754
+435% +$35.2M 0.23% 61
2022
Q4
$10.8M Sell
29,396
-22,244
-43% -$8.14M 0.14% 60
2022
Q3
$16.7M Sell
51,640
-32,319
-38% -$10.5M 0.23% 58
2022
Q2
$27.2M Sell
83,959
-43,795
-34% -$14.2M 0.34% 52
2022
Q1
$36.6M Hold
127,754
0.37% 54
2021
Q4
$35.3M Hold
127,754
0.32% 53
2021
Q3
$29.5M Hold
127,754
0.3% 57
2021
Q2
$29.3M Buy
127,754
+5,481
+4% +$1.26M 0.31% 52
2021
Q1
$22.8M Sell
122,273
-30,696
-20% -$5.73M 0.27% 53
2020
Q4
$25.8M Buy
152,969
+23,081
+18% +$3.9M 0.34% 52
2020
Q3
$19.2M Buy
129,888
+72,299
+126% +$10.7M 0.28% 52
2020
Q2
$9.46M Hold
57,589
0.15% 64
2020
Q1
$7.99M Buy
57,589
+13,049
+29% +$1.81M 0.16% 64
2019
Q4
$5.85M Hold
44,540
0.09% 90
2019
Q3
$4.98M Buy
44,540
+17,136
+63% +$1.92M 0.08% 90
2019
Q2
$3.04M Buy
27,404
+1,191
+5% +$132K 0.05% 109
2019
Q1
$3.4M Hold
26,213
0.07% 94
2018
Q4
$3.03M Sell
26,213
-7,088
-21% -$820K 0.07% 93
2018
Q3
$3.57M Buy
+33,301
New +$3.57M 0.07% 98